Alliance Pharma PLC Correction: Application for admission (6283E)
May 09 2017 - 08:50AM
UK Regulatory
TIDMAPH
RNS Number : 6283E
Alliance Pharma PLC
09 May 2017
For immediate release 9 May 2017
The following amendment has been made to the "Application for
admission" announcement released on 8 May 2017 at 2.30pm under RNS
4932E:
Application has been made for 66,815 ordinary shares to be
admitted to AIM rather than the 66,315 previously stated. All other
details remain unchanged.
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Application for admission
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces that following the exercise of employee share
options, application has been made by Alliance for a further 66,815
ordinary shares of 1p each in the Company ("Ordinary Shares") to be
admitted to trading on AIM.
It is expected that these new Ordinary Shares, which will rank
pari passu in all respects with the existing Ordinary Shares, will
be admitted to trading on 12 May 2017.
After admission, Alliance will have 472,963,997 Ordinary Shares
in issue.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Andrew Franklin, Chief Financial
Officer
Rob Bellhouse, Company Secretary
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: James
Black / Toby Adcock
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has sales in more than 100 countries worldwide via direct
sales, joint ventures and a network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Company continues to explore opportunities to expand its
product portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSBDGDUBXGBGRC
(END) Dow Jones Newswires
May 09, 2017 08:50 ET (12:50 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2023 to Mar 2024